CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
451-465 of 1225

Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors

RSV in Infants and Young Children: Are You Taking It Seriously Enough?
CME/CERSV in Infants and Young Children: Are You Taking It Seriously Enough?

Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care

A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
- advertisement

IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
CME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies

Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CEEngaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%

Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®

Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer

Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
MinuteCE®Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
- advertisement

Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
MinuteCE®Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates


















































